These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 4212198)
21. Problems in extrapolating toxicity data for laboratory animals to man. Dixon RL Environ Health Perspect; 1976 Feb; 13():43-50. PubMed ID: 817897 [TBL] [Abstract][Full Text] [Related]
22. Future drug research--drugs of the future. Gross F Clin Pharmacol Ther; 1973; 14(1):1-11. PubMed ID: 4630233 [No Abstract] [Full Text] [Related]
24. Application of pharmacokinetics and biopharmaceutics in the design of toxicological studies. Smyth RD; Hottendorf GH Toxicol Appl Pharmacol; 1980 Apr; 53(2):179-95. PubMed ID: 7394763 [No Abstract] [Full Text] [Related]
25. Some aspects of pharmacokinetic and biotransformation differences in humans and mammal animals. Chodera A; Feller K Int J Clin Pharmacol Biopharm; 1978 Aug; 16(8):357-60. PubMed ID: 99374 [TBL] [Abstract][Full Text] [Related]
27. Bioavailability of drugs: principles and problems. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser; 1973 Nov; 536():1-17. PubMed ID: 4204708 [No Abstract] [Full Text] [Related]
28. Antisense oligonucleotides on neurobehavior, respiratory, and cardiovascular function, and hERG channel current studies. Kim TW; Kim KS; Seo JW; Park SY; Henry SP J Pharmacol Toxicol Methods; 2014; 69(1):49-60. PubMed ID: 24211663 [TBL] [Abstract][Full Text] [Related]
29. Pharmacodynamic principles of drug therapy in the aged. Bender AD J Am Geriatr Soc; 1974 Jul; 22(7):296-303. PubMed ID: 4841255 [No Abstract] [Full Text] [Related]
30. [Social equivalents of the biological protective-adaptive mechanisms of animals and pharmacology]. Zheliazkov D Eksp Med Morfol; 1984; 23(1):1-8. PubMed ID: 6432514 [No Abstract] [Full Text] [Related]
31. [Prediction of the effect of xenobiotics on human beings]. Rybolovlev IuR Farmakol Toksikol; 1984; 47(1):110-4. PubMed ID: 6705898 [No Abstract] [Full Text] [Related]
32. Mixed Matrix Method Provides A Reliable Metabolite Exposure Comparison for Assessment of Metabolites in Safety Testing (MIST). Takahashi RH; Khojasteh C; Wright M; Hop CECA; Ma S Drug Metab Lett; 2017 Nov; 11(1):21-28. PubMed ID: 28699487 [TBL] [Abstract][Full Text] [Related]
38. Species choice in safety evaluation. Worden AN; Roberts CN Jpn J Pharmacol; 1972; 22():Suppl22:16. PubMed ID: 4627659 [No Abstract] [Full Text] [Related]
39. [Metabolism of drugs and drug security]. Rentsch GA Dtsch Med Wochenschr; 1975 Oct; 100(44):2285-92. PubMed ID: 1183328 [No Abstract] [Full Text] [Related]
40. Drug and chemical blood-level data 2001. Winek CL; Wahba WW; Winek CL; Balzer TW Forensic Sci Int; 2001 Nov; 122(2-3):107-23. PubMed ID: 11672964 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]